Recon: PTC gets FDA CRL for Friedreich’s ataxia drug; Pediatrics group breaks with HHS to recommend COVID vaccines for young children
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States